Join
Live feed
·
PRReleasevia Quantisnow
Qualigen Therapeutics Inc. logo

Qualigen Therapeutics Acquires Majority Stake in Infectious Disease Diagnostics Technology Company NanoSynex

ByQuantisnow·Wall Street's wire, on your screen.
QLGN· Qualigen Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QLGN (Qualigen Therapeutics Inc.) and more on Quantisnow.